RP5063

· Reviva Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RP5063, covering 2015-01-26 to 2015-01-26. Get the full timeline:

Most recent: Clinical Trial Update: RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder [Phase 2]